I suggest that the committee ask the Scottish Government to be vigilant about one aspect of that success, which is that it has been underpinned by the cost of individual treatments reducing. Because the target was around numbers, extra money had been provided but, rather than that money being used to give extra treatments it was used for other things. Clearly, there has been a shift back if more than the target number of treatments has been achieved. However, the reason for that was that the costs were reducing. I am concerned that there might be an opportunity cost—which, in some ways, could be seen as a loss—because the Government stuck rigidly to its target. Nevertheless, the evidence now suggests that the position has shifted again, because the Government has achieved more than its target.
If the committee were to close the petition, we could write to the Scottish Government, highlighting the importance that we place on the potential for eliminating the disease well ahead of the 2030 target but stressing the aspect of the cost of the treatments having reduced.
Do members agree to close the petition under rule 15.7 of the standing orders, on the basis that the Scottish Government has exceeded its treatment targets for 2019-20 and is working to agree treatment targets to eliminate hepatitis C in advance of the World Health Organization target date of 2030?
As has already been suggested, perhaps the committee could also thank the petitioner for engaging with us and raising an issue on which there needs to be continued vigilance. I have no doubt that, if the petitioner were to have continuing concerns, he would be able to bring back the petition a year after its closure.
Members indicated agreement.